Beijing BrilliantMed Pharmaceutical Technology Co., Ltd. (hereinafter referred to as BrilliantMed Pharmaceutical) was established in 2024 and is registered in Beijing, China. The company's main business direction is to provide high-quality global registration consulting and registration management operation services.
The core members of BrilliantMed Pharmaceutical come from Fortune 500 companies, including Bayer, Novo Nordisk, Sanofi, etc. Each member has more than 15 years of work experience in the pharmaceutical industry and possesses rich professional knowledge and skills.
Currently, our services mainly include formulating global registration strategies, executing local registration submissions, and publishing electronic submission documents on a global scale. We are committed to helping our clients understand the regulatory requirements of different regions, ensuring that various registration applications of their products can be submitted in a timely and accurate manner worldwide, so as to complete their global market layout.
Upholding the service concept of "integrity as the foundation and professionalism as the paramount", we continuously innovate and optimize our service processes to provide our clients with comprehensive and professional solutions. In an increasingly stringent regulatory environment, we are committed to providing efficient and compliant electronic submission services, and have won widespread recognition and trust within the industry.
Looking ahead, we will continue to strengthen technological innovation and service upgrades, promote the healthy development of the pharmaceutical industry, and create greater value for our clients. We look forward to cooperating with clients around the world to create brilliance together.